IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on March 29, 2016. The report discloses significant changes to the composition of the Board of Directors and associated compensatory arrangements.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data disclosed relates to director compensation:
- Anthony Vuoto (New Director): Granted 7,932 Restricted Stock Units (vesting in three equal annual installments starting March 28, 2017) and $52,500 in annual cash compensation.
- Cash Compensation Breakdown: $35,000 annual board retainer, $10,000 for Chairman of the Compensation Committee, and $7,500 for Audit Committee membership.
Material Changes
The filing reports the following material changes to corporate governance:
- Appointment: Anthony Vuoto was appointed to the Board of Directors, the Audit Committee, and as Chairman of the Compensation Committee.
- Departure: Jim Hawkins, current Chairman of the Board, will not stand for re-election at the Annual Meeting of Stockholders scheduled for June 10, 2016.
- Succession: Roger Susi, President and CEO, is nominated to serve as the new Chairman of the Board.
Outlook, Risks, and Management Commentary
The filing contains no financial guidance, outlook, or discussion of risks and contingencies. Management commentary is limited to the announcement of the board changes and the inclusion of a press release as Exhibit 99.1.
Key Facts for Investor Verification
- Verify the vesting schedule and performance conditions for the 7,932 Restricted Stock Units granted to Anthony Vuoto.
- Confirm the exact date and agenda for the Annual Meeting of Stockholders on June 10, 2016, regarding the election of directors.
- Review the full text of the press release (Exhibit 99.1) for additional context on the strategic rationale for the board changes.